Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats

Olanzapine, an atypical antipsychotic, is efficient in stress associated psychiatric diseases, but its effect on the liver, a primary organ for drug activation and detoxification, still remains unclear. The effect of olanzapine administration (7.5mg/kg/day), on rat hepatic glutathione (GSH)-dependen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Todorović, Nevena (VerfasserIn) , Gass, Peter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: European journal of pharmaceutical sciences
Year: 2015, Jahrgang: 81, Pages: 94-102
ISSN:1879-0720
DOI:10.1016/j.ejps.2015.10.010
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejps.2015.10.010
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0928098715300385
Volltext
Verfasserangaben:Nevena Todorović, Nada Tomanović, Peter Gass, Dragana Filipović

MARC

LEADER 00000caa a2200000 c 4500
001 1586487930
003 DE-627
005 20230427034211.0
007 cr uuu---uuuuu
008 190122r20162015xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ejps.2015.10.010  |2 doi 
035 |a (DE-627)1586487930 
035 |a (DE-576)516487930 
035 |a (DE-599)BSZ516487930 
035 |a (OCoLC)1341033891 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Todorović, Nevena  |e VerfasserIn  |0 (DE-588)1175998508  |0 (DE-627)1047145820  |0 (DE-576)516487884  |4 aut 
245 1 0 |a Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats  |c Nevena Todorović, Nada Tomanović, Peter Gass, Dragana Filipović 
264 1 |c 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.01.2019 
500 |a Available online 19 October 2015 
520 |a Olanzapine, an atypical antipsychotic, is efficient in stress associated psychiatric diseases, but its effect on the liver, a primary organ for drug activation and detoxification, still remains unclear. The effect of olanzapine administration (7.5mg/kg/day), on rat hepatic glutathione (GSH)-dependent defense and proinflammatory cytokines following 6weeks of chronic social isolation (CSIS), which causes depressive- and anxiety-like behavior in adult male Wistar rats, was investigated. The subcellular distribution of nuclear factor-κB (NF-κB), cytosolic inducible nitric oxide synthase (iNOS) protein levels and hepatic histological alterations were also determined. Decreased GSH content and glutathione reductase activity associated with increased catalase and glutathione S-transferase activity following CSIS indicated hepatic oxidative stress. Moreover, CSIS caused NF-κB nuclear translocation and the concomitant increase in iNOS together with increase in interleukin-1beta and tumor necrosis factor alpha protein levels, but no effect on interleukin-6. Olanzapine treatment suppressed NF-κB activation and iNOS expression and caused modulation of GSH-dependent defense systems but failed to reverse CSIS-induced increase in hepatic proinflammatory cytokines. Portal inflammation, focal hepatocyte necrosis and an increased number of Kupffer cells in CSIS rats (vehicle- or olanzapine-treated) were found. Olanzapine-treated socially reared rats showed portal inflammation and focal hepatocyte necrosis. Data suggest that CSIS compromised GSH-dependent defense, triggered a proinflammatory response and histological alterations in rat liver. Olanzapine treatment partially reversed the alterations in hepatic GSH-dependent defense, but showed no anti-inflammatory effect suggesting that it may provide protective effect against hepatic CSIS-induced oxidative stress, but not against inflammation. 
534 |c 2015 
650 4 |a Chronic social isolation 
650 4 |a Histopathology 
650 4 |a Inflammation 
650 4 |a Liver 
650 4 |a Olanzapine 
650 4 |a Oxidative stress 
700 1 |a Gass, Peter  |d 1963-  |e VerfasserIn  |0 (DE-588)13015945X  |0 (DE-627)492009694  |0 (DE-576)298033771  |4 aut 
773 0 8 |i Enthalten in  |t European journal of pharmaceutical sciences  |d New York, NY [u.a.] : Elsevier, 1993  |g 81(2016), Seite 94-102  |h Online-Ressource  |w (DE-627)300897308  |w (DE-600)1483522-8  |w (DE-576)094142033  |x 1879-0720  |7 nnas  |a Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats 
773 1 8 |g volume:81  |g year:2016  |g pages:94-102  |g extent:9  |a Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats 
856 4 0 |u http://dx.doi.org/10.1016/j.ejps.2015.10.010  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0928098715300385  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190122 
993 |a Article 
994 |a 2016 
998 |g 13015945X  |a Gass, Peter  |m 13015945X:Gass, Peter  |d 60000  |e 60000PG13015945X  |k 0/60000/  |p 3 
999 |a KXP-PPN1586487930  |e 3047069352 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Todorović","given":"Nevena","display":"Todorović, Nevena","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gass, Peter","given":"Peter","family":"Gass"}],"title":[{"title_sort":"Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats","title":"Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats"}],"recId":"1586487930","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.01.2019","Available online 19 October 2015"],"name":{"displayForm":["Nevena Todorović, Nada Tomanović, Peter Gass, Dragana Filipović"]},"id":{"eki":["1586487930"],"doi":["10.1016/j.ejps.2015.10.010"]},"origin":[{"dateIssuedDisp":"2016","dateIssuedKey":"2016"}],"relHost":[{"note":["Gesehen am 25.05.2020","Ungezählte Beil.: Supplement"],"disp":"Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated ratsEuropean journal of pharmaceutical sciences","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"300897308","language":["eng"],"pubHistory":["1.1993 -"],"part":{"volume":"81","text":"81(2016), Seite 94-102","extent":"9","year":"2016","pages":"94-102"},"titleAlt":[{"title":"Pharmaceutical sciences"}],"title":[{"title_sort":"European journal of pharmaceutical sciences","title":"European journal of pharmaceutical sciences","subtitle":"official journal of the European Federation for Pharmaceutical Sciences"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"New York, NY [u.a.]","dateIssuedDisp":"1993-","dateIssuedKey":"1993","publisher":"Elsevier"}],"id":{"eki":["300897308"],"zdb":["1483522-8"],"issn":["1879-0720"]}}],"physDesc":[{"extent":"9 S."}]} 
SRT |a TODOROVICNOLANZAPINE2016